Lv42
440 积分 2025-08-27 加入
Reprogramming CD22 CAR-T cells in vivo Using CD8-Targeted mRNA-LNPs to Treat Hematological Malignancies
3天前
已完结
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition
3天前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
7天前
已完结
Anlotinib: First Global Approval
9天前
已完结
Bcr-Abl Kinase Domain Mutations in Imatinib and in Second-Generation Tyrosine Kinase Inhibitor Eras: Seven Years of Mutation Analysis, a Report by the GIMEMA CML Working Party
12天前
已关闭
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer
13天前
已关闭
Primary cells in BCR/FGFR1‐positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib
17天前
已完结
Myeloproliferative disorder associated with 8p11 translocations [letter; comment]
17天前
已关闭
Increasing incidence of endometrial cancer demands global action
19天前
已关闭
Targeting molecular pathways in endometrial cancer: A focus on the FGFR pathway
21天前
已完结
皖公网安备34019202002308
